Lv2
120 积分 2025-03-06 加入
Food Allergy and Eosinophilic Gastrointestinal Diseases-The Next 10 Years
1天前
待确认
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
SODA (severity of dyspepsia assessment)
5个月前
已完结
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Advancements in Biologic Therapies for Eosinophilic Gastrointestinal Diseases
6个月前
已关闭
Eosinophilic gastrointestinal disorders and the role for the epithelium in pathogenesis and treatment
6个月前
已完结
Monoclonal Antibodies for Eosinophilic Esophagitis and Gastritis
6个月前
已完结
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
6个月前
已完结
Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
7个月前
已完结
DECREASING FREQUENCY OF DUPILUMAB IS ASSOCIATED WITH STABLE ASTHMA IN SELECT POPULATIONS
7个月前
已关闭